BioNTech SE - ADR vs Expedia Group Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Expedia Group Inc trades at $328 (market cap $38.53B). The key difference: Expedia Group Inc is the larger of the two by market cap, and Expedia Group Inc pays a 0.6% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | EXPE | |
|---|---|---|
Market Cap | $23.31B | $38.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $321.07 |
52-Week Low | $83.89 | $188.51 |
Enterprise Value | $6.60B | $37.09B |
Dividend Yield | — | 0.6% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →